Physician profile
Julie Messner
NPI 1588748917
$1,263.66
in general payments reported to CMS, 2019-2025
20 companies · $74.83 in 2025
The $74.83 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $48.44 · 2021: $551 · 2022: $14.67 · 2023: $206 · 2024: $144 · 2025: $74.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $467.32 | 2021-2022 | |
| Corium, LLC | $196.27 | 2023-2024 | Azstarys |
| Cranial Technologies, INC | $101.60 | 2019-2024 | Doc Band |
| Tris Pharma INC | $74.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $58.06 | 2019-2021 | |
| Pfizer INC. | $53.12 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $51.27 | 2019 | |
| Phadia US INC. | $32.60 | 2023-2024 | Immunocap |
| Sanofi Pasteur INC. | $25.03 | 2025 | |
| Soleno Therapeutics, INC. | $25.01 | 2025 | Vykat Xr |
| Alk-Abello, INC | $24.79 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $24.02 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $23.34 | 2019 | |
| Adlon Therapeutics L.P. | $18.33 | 2021 | |
| Kaleo, INC. | $16.50 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $15.64 | 2024 | Qsymia |
| Takeda Pharmaceuticals U.S.A., INC. | $15.16 | 2019 | |
| Merck Sharp & Dohme LLC | $14.83 | 2021 | |
| Neos Therapeutics, LP | $13.95 | 2024 | Cotempla Xr-Odt |
| Genentech USA, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Messner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.